BioMarin Pharmaceutical Inc.
BMRN
$60.43
$1.903.25%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 37.17% | 58.83% | 16.97% | 21.57% | 5.95% |
| Total Receivables | 37.50% | 1.64% | 23.82% | 16.01% | 4.23% |
| Inventory | 5.37% | 17.20% | 13.23% | 12.03% | 11.33% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -7.81% | 20.68% | 10.45% | 11.18% | 42.54% |
| Total Current Assets | 22.31% | 26.11% | 16.74% | 16.18% | 9.35% |
|
|
|||||
| Total Current Assets | 22.31% | 26.11% | 16.74% | 16.18% | 9.35% |
| Net Property, Plant & Equipment | -7.89% | -0.69% | -2.14% | -2.62% | -3.18% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -3.16% | -10.66% | -9.76% | -11.55% | -1.33% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.50% | 3.28% | -3.06% | -1.36% | 0.73% |
| Total Assets | 8.66% | 11.15% | 5.51% | 3.99% | 2.15% |
|
|
|||||
| Total Accounts Payable | 32.86% | 24.77% | 20.74% | 0.52% | -25.39% |
| Total Accrued Expenses | 19.03% | -7.08% | 8.09% | 6.30% | 6.33% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.67% | -5.98% | -98.48% | -98.75% | -98.49% |
| Total Finance Division Other Current Liabilities | 32.14% | 66.97% | 111.33% | 58.57% | -30.80% |
| Total Other Current Liabilities | 32.14% | 66.97% | 111.33% | 58.57% | -30.80% |
| Total Current Liabilities | 25.05% | 11.57% | -35.89% | -42.25% | -48.43% |
|
|
|||||
| Total Current Liabilities | 25.05% | 11.57% | -35.89% | -42.25% | -48.43% |
| Long-Term Debt | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 18.41% | -- | -- | -- | -18.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 16.64% | 27.87% | 24.67% | 10.51% | 19.26% |
| Total Liabilities | 13.23% | 8.37% | -19.74% | -24.76% | -29.58% |
|
|
|||||
| Common Stock & APIC | 2.66% | 2.81% | 2.72% | 3.11% | 3.39% |
| Retained Earnings | 179.20% | 162.81% | 154.38% | 98.31% | 68.68% |
| Treasury Stock & Other | -147.56% | -539.99% | -471.80% | 162.56% | 230.48% |
| Total Common Equity | 7.58% | 11.88% | 14.01% | 14.18% | 14.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.58% | 11.88% | 14.01% | 14.18% | 14.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.58% | 11.88% | 14.01% | 14.18% | 14.27% |
|
|
|||||